This kind of risk reduction is a very big deal for the millions of Americans who are overweight and already living with heart disease
Combining tirzepatide with hormone therapy adds roughly 35% more weight loss per Mayo Clinic ENDO 2025, especially relevant for hormonal belly fat redistribution
It begins with a licensed Registered Nurse consultation, followed by a Telemed visit with a Nurse Practitioner who will confirm your eligibility and create a personalized Plan
This makes physiological sense because the blood-sugar-regulating ingredients (chromium, mulberry leaf, fenugreek) work best when there are incoming carbohydrates to modulate
How it works
The reported results are promising: Over 80% relative bioavailability Around 160 higher bioavailability vs oral tablets Sustained drug levels for ~1 week (once-weekly dosing potential) Additionally, the microneedle patches are stable at room temperature, eliminating the need for cold storage, unlike semaglutide injections
